Pdt Partners, LLC Cardiovascular Systems Inc Transaction History

Pdt Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.93 - $17.17 $264,004 - $350,577	-20,418 Reduced 43.24%	26,804 $372,000
Q2 2022 Aug 15, 2022	BUY	$13.53 - $23.34 $391,287 - $674,992	28,920 Added 158.02%	47,222 $678,000
Q1 2022 May 16, 2022	BUY	$16.14 - $22.6 $90,190 - $126,288	5,588 Added 43.95%	18,302 $414,000
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $236,988 - $467,493	12,714 New	12,714 $239,000
Q2 2021 Aug 16, 2021	SELL	$34.41 - $44.03 $331,953 - $424,757	-9,647 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$37.29 - $47.19 $1,603 - $2,029	43 Added 0.45%	9,647 $370,000
Q4 2020 Feb 16, 2021	BUY	$34.3 - $44.09 $329,417 - $423,440	9,604 New	9,604 $420,000
Q2 2019 Aug 14, 2019	SELL	$33.93 - $43.66 $827,892 - $1.07 Million	-24,400 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$25.26 - $38.43 $227 - $345	-9 Reduced 0.04%	24,400 $695,000
Q3 2018 Nov 14, 2018	SELL	$33.27 - $39.25 $93,788 - $110,645	-2,819 Reduced 10.35%	24,409 $955,000
Q2 2018 Aug 14, 2018	BUY	$21.73 - $33.15 $591,664 - $902,608	27,228 New	27,228 $881,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.